The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy
Marie Lindefeldt, Alexander Eng, Hamid Darban, Annelie Bjerkner, Cecilia K Zetterström, Tobias Allander, Björn Andersson, Elhanan Borenstein, Maria Dahlin, Stefanie Prast-Nielsen, Marie Lindefeldt, Alexander Eng, Hamid Darban, Annelie Bjerkner, Cecilia K Zetterström, Tobias Allander, Björn Andersson, Elhanan Borenstein, Maria Dahlin, Stefanie Prast-Nielsen
Abstract
The gut microbiota has been linked to various neurological disorders via the gut-brain axis. Diet influences the composition of the gut microbiota. The ketogenic diet (KD) is a high-fat, adequate-protein, low-carbohydrate diet established for treatment of therapy-resistant epilepsy in children. Its efficacy in reducing seizures has been confirmed, but the mechanisms remain elusive. The diet has also shown positive effects in a wide range of other diseases, including Alzheimer's, depression, autism, cancer, and type 2 diabetes. We collected fecal samples from 12 children with therapy-resistant epilepsy before starting KD and after 3 months on the diet. Parents did not start KD and served as diet controls. Applying shotgun metagenomic DNA sequencing, both taxonomic and functional profiles were established. Here we report that alpha diversity is not changed significantly during the diet, but differences in both taxonomic and functional composition are detected. Relative abundance of bifidobacteria as well as E. rectale and Dialister is significantly diminished during the intervention. An increase in relative abundance of E. coli is observed on KD. Functional analysis revealed changes in 29 SEED subsystems including the reduction of seven pathways involved in carbohydrate metabolism. Decomposition of these shifts indicates that bifidobacteria and Escherichia are important contributors to the observed functional shifts. As relative abundance of health-promoting, fiber-consuming bacteria becomes less abundant during KD, we raise concern about the effects of the diet on the gut microbiota and overall health. Further studies need to investigate whether these changes are necessary for the therapeutic effect of KD.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- Mulle JG, Sharp WG, Cubells JF. The gut microbiome: a new frontier in autism research. Curr. Psychiatry Rep. 2013;15:337. doi: 10.1007/s11920-012-0337-0.
- Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36:305–312. doi: 10.1016/j.tins.2013.01.005.
- Cryan JF, O’Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol. Motil. 2011;23:187–192. doi: 10.1111/j.1365-2982.2010.01664.x.
- Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012;13:701–712. doi: 10.1038/nrn3346.
- Diaz Heijtz R, et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA. 2011;108:3047–3052. doi: 10.1073/pnas.1010529108.
- David LA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820.
- Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics. 2007;119:535–543. doi: 10.1542/peds.2006-2447.
- Neal EG, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50:1109–1117. doi: 10.1111/j.1528-1167.2008.01870.x.
- Freeman JM, et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102:1358–1363. doi: 10.1542/peds.102.6.1358.
- Rogawski, M. A., Löscher, W. & Rho, J. M. Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb. Perspect. Med. (2016).
- Greenhalgh K, Meyer KM, Aagaard KM, Wilmes P. The human gut microbiome in health: establishment and resilience of microbiota over a lifetime. Environ. Microbiol. 2016;18:2103–2116. doi: 10.1111/1462-2920.13318.
- Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. doi: 10.1186/gb-2011-12-6-r60.
- Kouse AB, Righetti F, Kortmann J, Narberhaus F, Murphy ER. RNA-mediated thermoregulation of iron-acquisition genes in Shigella dysenteriae and pathogenic Escherichia coli. PLoS One. 2013;8:e63781. doi: 10.1371/journal.pone.0063781.
- Létoffé S, Delepelaire P, Wandersman C. The housekeeping dipeptide permease is the Escherichia coli heme transporter and functions with two optional peptide binding proteins. Proc. Natl. Acad. Sci. USA. 2006;103:12891–12896. doi: 10.1073/pnas.0605440103.
- Runyen-Janecky LJ. Role and regulation of heme iron acquisition in gram-negative pathogens. Front. Cell Infect. Microbiol. 2013;3:55. doi: 10.3389/fcimb.2013.00055.
- Bramanti TE, Holt SC. Effect of porphyrins and host iron transport proteins on outer membrane protein expression in Porphyromonas (Bacteroides) gingivalis: identification of a novel 26 kDa Hemin-repressible surface protein. Microb. Pathog. 1992;13:61–73. doi: 10.1016/0882-4010(92)90032-J.
- Bramanti TE, Holt SC. Iron-regulated outer membrane proteins in the periodontopathic bacterium, Bacteroides gingivalis. Biochem. Biophys. Res. Commun. 1990;166:1146–1154. doi: 10.1016/0006-291X(90)90986-W.
- Gibbons RJ, Macdonald JB. Hemin and vitamin K compounds as required factors for the cultivation of certain strains of Bacteroides melaninogenicus. J. Bacteriol. 1960;80:164–170.
- Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457–D462. doi: 10.1093/nar/gkv1070.
- Vital, M., Karch, A. & Pieper, D. H. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems10.1128/mSystems.00130-17 (2017).
- Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio. 2014;5:e00889. doi: 10.1128/mBio.00889-14.
- Olson CA, et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;173:1728.e13–1741.e13. doi: 10.1016/j.cell.2018.04.027.
- Medel-Matus JS, Shin D, Dorfman E, Sankar R, Mazarati A. Facilitation of kindling epileptogenesis by chronic stress may be mediated by intestinal microbiome. Epilepsia Open. 2018;3:290–294. doi: 10.1002/epi4.12114.
- He Z, et al. Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: the first report. World J. Gastroenterol. 2017;23:3565–3568. doi: 10.3748/wjg.v23.i19.3565.
- Turroni, F. et al. Glycan utilization and cross-feeding activities by Bifidobacteria. Trends Microbiol. 10.1016/j.tim.2017.10.001 (2017).
- Scardovi V, Trovatelli LD. The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann. Microbiol. Enzimol. 1965;15:19–29.
- Duncan SH, et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007;73:1073–1078. doi: 10.1128/AEM.02340-06.
- Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547. doi: 10.1038/nature09646.
- Agus A, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent-invasive E. coli infection and intestinal inflammation. Sci. Rep. 2016;6:19032. doi: 10.1038/srep19032.
- Conway, T. & Cohen, P. S. Commensal and pathogenic Escherichia coli metabolism in the gut. Microbiol. Spectr. 10.1128/microbiolspec.MBP-0006-2014 (2015).
- Singh V, et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun. 2015;6:7113. doi: 10.1038/ncomms8113.
- Rivière A, Gagnon M, Weckx S, Roy D, De Vuyst L. Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 explain the bifidogenic and butyrogenic effects of arabinoxylan oligosaccharides. Appl. Environ. Microbiol. 2015;81:7767–7781. doi: 10.1128/AEM.02089-15.
- Cockburn DW, et al. Novel carbohydrate binding modules in the surface anchored α-amylase of Eubacterium rectale provide a molecular rationale for the range of starches used by this organism in the human gut. Mol. Microbiol. 2018;107:249–264. doi: 10.1111/mmi.13881.
- Duncan SH, et al. Wheat bran promotes enrichment within the human colonic microbiota of butyrate-producing bacteria that release ferulic acid. Environ. Microbiol. 2016;18:2214–2225. doi: 10.1111/1462-2920.13158.
- Huda-Faujan N, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem. J. 2010;4:53–58. doi: 10.2174/1874091X01004010053.
- Chen HM, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am. J. Clin. Nutr. 2013;97:1044–1052. doi: 10.3945/ajcn.112.046607.
- Segain JP, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut. 2000;47:397–403. doi: 10.1136/gut.47.3.397.
- Lührs H, et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 2002;37:458–466. doi: 10.1080/003655202317316105.
- Maslowski KM, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286. doi: 10.1038/nature08530.
- Macia L, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 2015;6:6734. doi: 10.1038/ncomms7734.
- Singh N, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128–139. doi: 10.1016/j.immuni.2013.12.007.
- Vinolo MAR, et al. Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice. Am. J. Physiol. Endocrinol. Metab. 2012;303:E272–E282. doi: 10.1152/ajpendo.00053.2012.
- Kelly CJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662–671. doi: 10.1016/j.chom.2015.03.005.
- Kinoshita M, Suzuki Y, Saito Y. Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. Biochem. Biophys. Res. Commun. 2002;293:827–831. doi: 10.1016/S0006-291X(02)00294-2.
- Tagliabue A, et al. Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: a 3-month prospective observational study. Clin. Nutr. ESPEN. 2017;17:33–37. doi: 10.1016/j.clnesp.2016.11.003.
- Xie G, et al. Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy. World J. Gastroenterol. 2017;23:6164–6171. doi: 10.3748/wjg.v23.i33.6164.
- Zhang Y, et al. Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Res. 2018;145:163–168. doi: 10.1016/j.eplepsyres.2018.06.015.
- Gómez-Eguílaz, M., Ramón-Trapero, J. L., Pérez-Martínez, L. & Blanco, J. R. The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: a pilot study. Benef. Microbes.9, 875–881 (2018).
- Ma D, et al. Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci. Rep. 2018;8:6670. doi: 10.1038/s41598-018-25190-5.
- De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA. 2010;107:14691–14696. doi: 10.1073/pnas.1005963107.
- Schroeder BO, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe. 2018;23:27.e7–40.e7. doi: 10.1016/j.chom.2017.11.004.
- Desai MS, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167:1339.e21–1353.e21. doi: 10.1016/j.cell.2016.10.043.
- Turroni F, Berry D, Ventura M. Editorial: bifidobacteria and their role in the human gut microbiota. Front. Microbiol. 2016;7:2148. doi: 10.3389/fmicb.2016.00865.
- Allen BG, et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2014;2C:963–970. doi: 10.1016/j.redox.2014.08.002.
- Scheck AC, Abdelwahab MG, Fenton KE, Stafford P. The ketogenic diet for the treatment of glioma: insights from genetic profiling. Epilepsy Res. 2012;100:327–337. doi: 10.1016/j.eplepsyres.2011.09.022.
- Barañano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 2008;10:410–419. doi: 10.1007/s11940-008-0043-8.
- Storoni M, Plant GT. The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis. Mult. Scler. Int. 2015;2015:681289.
- Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed. Res. Int. 2014;2014:474296. doi: 10.1155/2014/474296.
- Hartman AL, Vining EPG. Clinical aspects of the ketogenic diet. Epilepsia. 2007;48:31–42. doi: 10.1111/j.1528-1167.2007.00914.x.
- Berg AT, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676–685. doi: 10.1111/j.1528-1167.2010.02522.x.
- Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv. Pediatr. 1997;44:297–329.
- Introducing BBDuk: Adapter/Quality Trimming and Filtering - SEQanswers at <>.
- BBMap download | at <>.
- Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047–3048. doi: 10.1093/bioinformatics/btw354.
- Truong DT, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods. 2015;12:902–903. doi: 10.1038/nmeth.3589.
- Sunagawa S, et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods. 2013;10:1196–1199. doi: 10.1038/nmeth.2693.
- Cleary JG, et al. Joint variant and de novo mutation identification on pedigrees from high-throughput sequencing data. J. Comput. Biol. 2014;21:405–419. doi: 10.1089/cmb.2014.0029.
- Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic classification for metagenomics with Kaiju. Nat. Commun. 2016;7:11257. doi: 10.1038/ncomms11257.
- Silva GGZ, Green KT, Dutilh BE, Edwards RA. SUPER-FOCUS: a tool for agile functional analysis of shotgun metagenomic data. Bioinformatics. 2016;32:354–361. doi: 10.1093/bioinformatics/btv584.
- Overbeek R, et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005;33:5691–5702. doi: 10.1093/nar/gki866.
- Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat. Methods. 2015;12:59–60. doi: 10.1038/nmeth.3176.
- Manor O, Borenstein E. Systematic characterization and analysis of the taxonomic drivers of functional shifts in the human microbiome. Cell Host Microbe. 2017;21:254–267. doi: 10.1016/j.chom.2016.12.014.
- Li H, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352.
Source: PubMed